SEC Tracker
Get the app

Milestone Pharmaceuticals MIST

Milestone Pharmaceuticals notified of Nasdaq noncompliance

Item 3.01 Listing standards notice

Form
8-K
Filed
Importance
Major
  1. Received notice of noncompliance with Nasdaq Listing Rule 5,450(a)(1)
  2. Minimum bid price below $1.00 for 30 consecutive days
  3. 180-day compliance period until April 21, 2027
  4. Potential transfer to Nasdaq Capital Market if compliance not met

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Milestone Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Assembly Biosciences ASMB public float $98M, Jun 30, 2025
  2. DiaMedica Therapeutics DMAC public float $96M, Jun 30, 2025
  3. Ironwood Pharmaceuticals IRWD public float $103M, Jun 30, 2025
  4. Vaxart VXRT public float $103M, Jun 30, 2025
  5. Larimar Therapeutics LRMR public float $95M, Jun 30, 2025